Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$159K
Net Open-Market Flow
-$159K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 28, 2026Sell(S)12$154.65$2K8K
Apr 28, 2026Sell(S)8$155.36$1K8K
Apr 28, 2026Sell(S)53$156.61$8K8K
Apr 28, 2026Sell(S)222$157.49$35K7K
Apr 28, 2026Sell(S)62$158.71$10K7K
Apr 28, 2026Sell(S)380$159.42$61K7K
Apr 28, 2026Sell(S)120$160.27$19K7K
Apr 28, 2026Sell(S)89$161.72$14K7K
Apr 28, 2026Sell(S)54$162.14$9K7K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-191929) within minutes of acceptance. Every field above traces to the original document. Verify it directly: